FDA Eyes Alpharma's Embeda Over Abuse Effects
By Erin Marie Daly ( November 12, 2008, 12:00 AM EST) -- U.S. Food and Drug Administration officials are concerned that design features meant to cut down on abuse of Alpharma Inc.'s Embeda aren't enough to prevent addicts from misusing the potent painkiller....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.